Zearalenone exposure may increase the risk of non-alcoholic fatty liver disease by activating CYP1B1-SCD1

ABSTRACT:

SUBMITTER: Ruan H 

PROVIDER: S-EPMC12771349 | biostudies-literature | 2025 Dec

REPOSITORIES: biostudies-literature